| Today marks an important day for U.S. trade with the passage of H.R. 1314, the Trade Priorities and Accountability Act, which reauthorizes the Trade Promotion Authority (TPA) and strengthens Congress’ role in trade policy. Without the TPA, President Obama would be calling the shots when it comes to trade and Congress would have little to no input.
However, this legislation promises congressional oversight and more transparency with trade negotiations. According to the nonpartisan Congressional Research Service, the TPA grants no new power to the president and instead gives authority back to Congress, allowing us to read through and make changes to any trade deal before voting on it. With the TPA, we can establish our expectations to the president, rather than being susceptible to his unilateral whims. Read my full statement here.
Also this week, I was privileged to be the keynote speaker at the annual National Leadership Summit on 340B. The Summit was held to allow stakeholders of 340B to come together to identify ways to ensure the program adheres to its original intent, to help Medicare patients afford expensive prescription drugs, and remains sustainable by driving critical improvements. I spoke on the need for transparency and oversight within the program and heard other innovative ideas from leaders in the healthcare community.
I hope you will scroll down to see more of what my week looked like. As always, please reach out to my office if there is anything I can do for you.
|